Literature DB >> 7438544

Suppression of leucocyte chemokinesis and chemotaxis by human IgA.

A S Kemp, A W Cripps, S Brown.   

Abstract

The effects of IgA and IgG isolated from normal human serum on neutrophil and monocyte migration were examined. IgA inhibited neutrophil chemotaxis towards casein and neutrophil random migration in serum-containing medium. The dose-response curve for the inhibition of the two forms of stimulated cell movement was similar suggesting that inhibition of both forms of movement may occur by a common mechanism. It was concluded that the inhibition was mediated by polymeric and aggregated forms of IgA but not by IgA present in normal serum. IgA at concentrations which inhibited stimulated cell movement did not inhibit the phagocytosis of zymosan particles by neutrophils. In contrast to IgA, aggregated IgG did not inhibit neutrophil chemotaxis at concentrations which were markedly inhibitory to random migration in serum-containing medium, indicating a differential effect of IgA and IgG aggregates on cell migration.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7438544      PMCID: PMC1536983     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  14 in total

Review 1.  Pathology of chemotaxis and random mobility.

Authors:  M E Miller
Journal:  Semin Hematol       Date:  1975-01       Impact factor: 3.851

2.  Immunoglobulins cytophilic for human lymphocytes, monocytes, and neutrophils.

Authors:  D A Lawrence; W O Weigle; H L Spiegelberg
Journal:  J Clin Invest       Date:  1975-02       Impact factor: 14.808

3.  A proposal for the definition of terms related to locomotion of leucocytes and other cells.

Authors:  H U Keller; P C Wilkinson; M Abercrombie; E L Becker; J G Hirsch; M E Miller; W Scottramsey; S H Zigmond
Journal:  Clin Exp Immunol       Date:  1977-03       Impact factor: 4.330

4.  Suppression of human PMN bactericidal activity by human IgA paraproteins.

Authors:  D E Van Epps; K Reed; R C Williams
Journal:  Cell Immunol       Date:  1978-03-15       Impact factor: 4.868

5.  Studies on the opsonic activity of human secretory IgA using an in vitro phagocytosis system.

Authors:  I D Wilson
Journal:  J Immunol       Date:  1972-03       Impact factor: 5.422

6.  The C3-activator system: an alternate pathway of complement activation.

Authors:  O Götze; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1971-09-01       Impact factor: 14.307

7.  Lack of opsonization potential of 11S human secretory A.

Authors:  A Zipursky; E J Brown; J Bienenstock
Journal:  Proc Soc Exp Biol Med       Date:  1973-01

8.  Chemotaxis of eosinophils and neutrophils by aggregated immunoglobulins.

Authors:  C E Laster; G J Gleich
Journal:  J Allergy Clin Immunol       Date:  1971-11       Impact factor: 10.793

Review 9.  Cellular aspects of immunoglobulin A.

Authors:  M E Lamm
Journal:  Adv Immunol       Date:  1976       Impact factor: 3.543

10.  Suppression of leukocyte chemotaxis by human IgA myeloma components.

Authors:  D E Van Epps; R C Williams
Journal:  J Exp Med       Date:  1976-11-02       Impact factor: 14.307

View more
  11 in total

1.  Studies of polymorphonuclear migration into psoriatic skin using a new in vivo method.

Authors:  B Guillot; M Coupe; M Alirezai; J P Bureau; J J Guilhou
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

Review 2.  Defense mechanisms involving Fc-dependent functions of immunoglobulin A and their subversion by bacterial immunoglobulin A proteases.

Authors:  M Kilian; J Mestecky; M W Russell
Journal:  Microbiol Rev       Date:  1988-06

3.  Identification of an IgA inhibitor of neutrophil chemotaxis and its membrane target for the metabolic burst.

Authors:  J N Moy; R D Nelson; K L Richards; M K Hostetter
Journal:  Immunology       Date:  1990-02       Impact factor: 7.397

4.  Subcorneal pustular dermatosis of Sneddon-Wilkinson. A long-term immunologic case study.

Authors:  G Schieferstein; N Brattig; P A Berg; R Dopfer
Journal:  Arch Dermatol Res       Date:  1984       Impact factor: 3.017

5.  Neutrophil function in chronic liver disease.

Authors:  A C Campbell; M W Dronfield; P J Toghill; W G Reeves
Journal:  Clin Exp Immunol       Date:  1981-07       Impact factor: 4.330

6.  Characterization of the IgA receptor from human polymorphonuclear leucocytes.

Authors:  M Albrechtsen; G R Yeaman; M A Kerr
Journal:  Immunology       Date:  1988-06       Impact factor: 7.397

7.  Human protein HC and its IgA complex are inhibitors of neutrophil chemotaxis.

Authors:  E Méndez; J L Fernández-Luna; A Grubb; F Leyva-Cobián
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

8.  Serum inhibition of complement derived leukocyte chemotaxis and levels of immunoglobulin A subclass in alcoholic liver disease.

Authors:  S Onishi; T Saibara; T Maeda; Y Yamamoto; K Ito
Journal:  Gastroenterol Jpn       Date:  1989-06

9.  Chemotactic properties of rat immunoglobulins and immune complexes.

Authors:  M Arashi; Y Sibille; W W Merrill; M Rits; H Bazin; J P Vaerman
Journal:  Infect Immun       Date:  1989-02       Impact factor: 3.441

10.  Inhibition of neutrophil migration by serum IgA from patients with IgA nephropathy.

Authors:  J Egido; J Sancho; F Lorente; G Fontan
Journal:  Clin Exp Immunol       Date:  1982-09       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.